The effect of recipient kidney function by Ber coadministration CsA used to induce immune tolerance in rats of allogenic cardiac transplantation

倪兴华,曾耀英,狄静芳,何贤辉,刘统成,林奕,谢闻悦,曾山,冯诤
DOI: https://doi.org/10.3321/j.issn:1001-1978.2003.10.028
2003-01-01
Abstract:AIM: To investigate the effect of recipient kidney function by CsA coadministration Ber used to induce immune tolerance in rats of allogenic cardiac transplantation. METHODS: The authors established the SD to Wistar rats heterotopic cardiac transplantation model by Ono's methods. Observe the cardiac allograft survival and levels of BUN and Cr in the recipients' plasma. The recipients were classified into 5 groups randomly after heterotopic cardiac transplantation were performed. Group A (Wistar to Wistar)). Received placebo intraperitoneal injected for 21 days; Group B (SD to Wistar): Saline intraperitoneal injected for 21 days; Group C (SD to Wistar): CsA 2 mg · kg-1 · d-1 intraperitoneal injected for 21 days; Group D(SD to Wistar): Ber 16 mg · kg-1 · d -1 gastrointubation for 21 days; Group E(SD to Wistar): Ber 16 mg · kg-1 · d-1 gastrointubation coadministration CsA 2 mg · kg-1 · d-1 ip for 21 days. RESULTS:1 The levels of BUN and Cr in recipint plasma is lower evidently compare with the group with CsA ip simply. CONCLUSION: Ber can reduce the renal toxicity in recipients by CsA which was intraperitoneal injected (ip) over a long period time.
What problem does this paper attempt to address?